Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Brain Injuries D001930 4 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Joly F et al. Ketotifen inhibits paf-acether biosynthesis and beta-hexosaminidase release in mouse mast cells stimulated with antigen. 1987 Eur. J. Pharmacol. pmid:2963750
Lagente V et al. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig. 1987 Prostaglandins pmid:2438723
Tselepis AD et al. Electrocardiographic alterations induced by AGEPC in Wistar rats in relation to its hypotensive and hematologic effects. 1987 Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. pmid:2885139
Hayashi M et al. Characterization of the activity of a platelet activating factor antagonist, CV-3988. 1987 Jpn. J. Pharmacol. pmid:2888915
Bussolino F et al. Chick retina generates platelet-activating factor. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2890284
Mikashima H et al. An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding. 1987 Jpn. J. Pharmacol. pmid:2890779
Gautheron PD et al. A study of PAF-induced ocular inflammation in the rat and its inhibition by the PAF antagonist, L-652,731. 1987 J. Pharm. Pharmacol. pmid:2891830
Kornecki E et al. Interactions of the alkyl-ether-phospholipid, platelet activating factor (PAF) with platelets, neural cells, and the psychotropic drugs triazolobenzodiazepines. 1987 Adv. Exp. Med. Biol. pmid:2893525
Gordeev KIu et al. [Synthesis of 1-(1-alkenyl)-2-acetyl-sn-glycero-3-phosphocholines, the aldehyded analogs of platelet activating factor]. 1987 Bioorg. Khim. pmid:3566815
Stahl GL and Lefer AM Heterogeneity of vascular smooth muscle responsiveness to lipid vasoactive mediators. 1987 Blood Vessels pmid:3567363
Kumar R et al. Metabolism of platelet-activating factor (alkylacetylphosphocholine) by type-II epithelial cells and fibroblasts from rat lungs. 1987 Biochim. Biophys. Acta pmid:3790610
O'Flaherty JT et al. 1-O-alkyl-2-N-methylcarbamyl-glycerophosphocholine: a biologically potent, non-metabolizable analog of platelet-activating factor. 1987 Biochem. Biophys. Res. Commun. pmid:2820395
Wymann MP et al. Oscillatory motion in human neutrophils responding to chemotactic stimuli. 1987 Biochem. Biophys. Res. Commun. pmid:2820398
Doly M et al. Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist. 1987 Immunopharmacology pmid:3038784
Homma H et al. Binding and internalization of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in washed rabbit platelets. 1987 J. Biol. Chem. pmid:3038889
Braquet P et al. Platelet-activating factor: a potential mediator of shock. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960197
Myers A et al. Pharmacological manipulation of platelet-activating factor toxicity in rodents. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960198
Sipka S et al. Atropine is an inhibitor of the chemiluminescence induced by platelet-activating factor in human neutrophils. 1987 Acta Biochim. Biophys. Hung. pmid:3132002
Rylander R and Beijer L Inhalation of endotoxin stimulates alveolar macrophage production of platelet-activating factor. 1987 Am. Rev. Respir. Dis. pmid:3541718
Dejana E et al. Modulation of endothelial cell functions by different molecular species of interleukin 1. 1987 Blood pmid:3542082
Lucchesi BR et al. Interaction of the formed elements of blood with the coronary vasculature in vivo. 1987 Fed. Proc. pmid:3542578
Stafforini DM et al. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. 1987 J. Biol. Chem. pmid:3549727
Nunez D et al. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions]. 1987 Pathol. Biol. pmid:3550639
Chang SW et al. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. 1987 J. Clin. Invest. pmid:3553241
Joseph R et al. Sensitivity to PAF is increased in migraine patients. 1987 Thromb. Haemost. pmid:3590077
Valone FH Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers. 1987 Thromb. Res. pmid:3590086
Tokumura A et al. Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists. 1987 Thromb. Res. pmid:3590110
Bamford CH et al. Polymeric inhibitors of platelet aggregation. II. Copolymers of dipyridamole and related drugs with N-vinylpyrrolidone. 1987 Biochim. Biophys. Acta pmid:3828396
Christman BW et al. Effect of platelet-activating factor on aerosol histamine responsiveness in awake sheep. 1987 Am. Rev. Respir. Dis. pmid:3592402
Benveniste J A role for paf-acether (platelet-activating factor) in bronchial hyperreactivity? 1987 Am. Rev. Respir. Dis. pmid:3592414
Tokumura A et al. Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain. 1987 Biochem. Biophys. Res. Commun. pmid:3593346
Kojima S et al. Cooperativity between platelet-activating factor and collagen in platelet aggregation. 1987 Biochem. Biophys. Res. Commun. pmid:3593379
Lapointe DS et al. Mobilization of hepatic calcium pools by platelet activating factor. 1987 Biochemistry pmid:3593678
Fujita K et al. Synthesis and biological activity of fluorine-modified platelet activating factors. 1987 Chem. Pharm. Bull. pmid:3594676
Rola-Pleszczynski M et al. Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021. 1987 Biochem. Biophys. Res. Commun. pmid:3493773
Bruijnzeel PL et al. Platelet-activating factor induces leukotriene C4 synthesis by purified human eosinophils. 1987 Prostaglandins pmid:3118415
Sha'afi RI and Molski TF Signalling for increased cytoskeletal actin in neutrophils. 1987 Biochem. Biophys. Res. Commun. pmid:3036146
Taylor RR et al. Whole blood platelet aggregation is not affected by cigarette smoking but is sex-related. 1987 Clin. Exp. Pharmacol. Physiol. pmid:3440324
Knox P et al. Role of plasminogen, plasmin, and plasminogen activators in the migration of fibroblasts into plasma clots. 1987 J. Cell. Physiol. pmid:2958486
Pettipher ER et al. PAF-acether in chronic arthritis. 1987 Agents Actions pmid:3630862
Stenmark KR et al. Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia. 1987 Am. Rev. Respir. Dis. pmid:3631747
Pretolani M et al. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs. 1987 Eur. J. Pharmacol. pmid:3653247
O'Donnell SR and Barnett CJ Microvascular leakage to platelet activating factor in guinea-pig trachea and bronchi. 1987 Eur. J. Pharmacol. pmid:3040440
Okayasu T et al. Platelet-activating factor stimulates metabolism of phosphoinositides via phospholipase A2 in primary cultured rat hepatocytes. 1987 J. Lipid Res. pmid:3040878
Deguchi K et al. [Platelet activating factor]. 1987 Nippon Rinsho pmid:3041069
Hurst JS et al. Effects of the lipid peroxidation product 4-hydroxynonenal on the aggregation of human platelets. 1987 Chem. Biol. Interact. pmid:3103933
Grigorian GY and Ryan US Platelet-activating factor effects on bovine pulmonary artery endothelial cells. 1987 Circ. Res. pmid:3040294
Morganroth ML et al. Decreased pulmonary vascular responsiveness in rats raised on an essential fatty acid deficient diet. 1987 Prostaglandins pmid:3108962
Nakamura T et al. Platelet-activating factor in late asthmatic response. 1987 Int. Arch. Allergy Appl. Immunol. pmid:3804454
Haroldsen PE et al. Quantitation of lyso-platelet activating factor molecular species from human neutrophils by mass spectrometry. 1987 J. Lipid Res. pmid:3104521
Wallace JL et al. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. 1987 Gastroenterology pmid:3305134
Barnes PJ The changing face of asthma. 1987 Q. J. Med. pmid:3310071
Schellenberg RR Airway responses to platelet-activating factor. 1987 Am. Rev. Respir. Dis. pmid:3310779
Makowka L et al. Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response. 1987 Ann. Surg. pmid:3310931
Mest HJ et al. Relevance of eicosanoids for biochemical regulation of cardiac rhythm disturbances. 1987 Biomed. Biochim. Acta pmid:3325045
Hanahan DJ and Kumar R Platelet activating factor; chemical and biochemical characteristics. 1987 Prog. Lipid Res. pmid:3313430
Bloom JW et al. Intravenous platelet activating factor does not affect lung epithelial permeability. 1987 Res. Commun. Chem. Pathol. Pharmacol. pmid:3326081
de Almeida PJ et al. [Biochemical bases of platelet activity in homeostasis and thrombogenesis. III]. 1987 Arq. Bras. Cardiol. pmid:3328601
O'Neill C Embryo-derived platelet activating factor: a preimplantation embryo mediator of maternal recognition of pregnancy. 1987 Domest. Anim. Endocrinol. pmid:3333935
Teng CM et al. Antiplatelet effect of butylidenephthalide. 1987 Biochim. Biophys. Acta pmid:3109495
Steel G et al. Failure of prostaglandin E2 and its 16,16-dimethyl analogue to prevent the gastric mucosal damage induced by Paf. 1987 Br. J. Pharmacol. pmid:3470106
Tamura N et al. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects. 1987 Biochem. Biophys. Res. Commun. pmid:3030295
Schwertschlag U et al. L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney. 1987 Circ. Res. pmid:3297384
O'Flaherty JT Phospholipid metabolism and stimulus-response coupling. 1987 Biochem. Pharmacol. pmid:3030324
Page CP A role for platelet activating factor and platelets in the induction of bronchial hyperreactivity. 1987 Int J Tissue React pmid:3298115
Lian EC Pathogenesis of thrombotic thrombocytopenic purpura. 1987 Semin. Hematol. pmid:3299722
Camussi G et al. Release of platelet-activating factor from rabbit heart perfused in vitro by sera with transplantation alloantibodies. 1987 Transplantation pmid:3299910
Zimmerman GA et al. Production of platelet-activating factor, a biologically active lipid, by vascular endothelial cells. 1987 Am. Rev. Respir. Dis. pmid:3300444
Murphy RC and Clay KL Measurement of platelet-activating factor by physicochemical technique s. 1987 Am. Rev. Respir. Dis. pmid:3300445
Braquet P et al. Perspectives in platelet-activating factor research. 1987 Pharmacol. Rev. pmid:3303066
Chen DC [Phosphoinositide metabolism and platelet activation]. 1987 Sheng Li Ke Xue Jin Zhan pmid:2838899
Murphy WG et al. Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura. 1987 Br. J. Haematol. pmid:3499167
Suemune H et al. Asymmetric synthesis of (+)- and (-)-batyl alcohol, a key synthetic intermediate for platelet-activating factor, by using biocatalysts. 1987 Chem. Pharm. Bull. pmid:3427701
Hwang SB Specific receptor sites for platelet activating factor on rat liver plasma membranes. 1987 Arch. Biochem. Biophys. pmid:2821908
Parker CW Lipid mediators produced through the lipoxygenase pathway. 1987 Annu. Rev. Immunol. pmid:3036183
Chung KF et al. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. 1987 Lancet pmid:2880069
Casals-Stenzel J and Weber KH Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity. 1987 Br. J. Pharmacol. pmid:2880622
Robaut C et al. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets. 1987 Biochem. Pharmacol. pmid:2822048
Dale MM and Penfield A Comparison of the effects of indomethacin, RHC80267 and R59022 on superoxide production by 1,oleoyl-2,acetyl glycerol and A23187 in human neutrophils. 1987 Br. J. Pharmacol. pmid:2822195
Leff AR et al. Parasympathetic involvement in PAF-induced contraction in canine trachealis in vivo. 1987 J. Appl. Physiol. pmid:2881917
Spinks NR and O'Neill C Embryo-deprived platelet-activating factor is essential for establishment of pregnancy in the mouse. 1987 Lancet pmid:2432367
Livio M et al. A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2823570
Khandwala A et al. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release. 1987 Biochem. Pharmacol. pmid:2435293
Stenzel H et al. Effect of the PAF-antagonist SRI 63-441 on the allergic reaction in awake dogs with natural asthma. 1987 Agents Actions Suppl. pmid:2823582
Alloatti G et al. Protective effect of verapamil on the cardiac and circulatory alterations induced by platelet-activating factor. 1987 J. Cardiovasc. Pharmacol. pmid:2435996
Kappa JR et al. Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374). 1987 J. Vasc. Surg. pmid:2437338
Gateau O [Role of PAF-acether (platelet activating factor) in cardio-vascular pathology]. 1987 Arch Mal Coeur Vaiss pmid:3117010
Serafin WE and Austen KF Mediators of immediate hypersensitivity reactions. 1987 N. Engl. J. Med. pmid:2438554
Altin JG et al. Evidence that Ca2+ fluxes and respiratory, glycogenolytic and vasoconstrictive effects induced by the action of platelet-activating factor and L-alpha-lysophosphatidylcholine in the perfused rat liver are mediated by products of the cyclo-oxygenase pathway. 1987 Biochem. J. pmid:3117040
Avdonin PV et al. Evidence for the receptor-operated calcium channels in human platelet plasma membrane. 1987 Thromb. Res. pmid:2438805
Terashita Z et al. A lethal role of platelet activating factor in anaphylactic shock in mice. 1987 J. Pharmacol. Exp. Ther. pmid:3118009
de Arriba G et al. Changes in glomerular cross-sectional area induced by platelet activating factor. 1987 Nephrol. Dial. Transplant. pmid:3118261
Morley J and Sanjar S PAF, ketotifen and asthma. 1987 N. Z. Med. J. pmid:3468405
Darius H and Lefer AM Pharmacologic antagonism of platelet activating factor and peptide leukotrienes inhibits guinea pig anaphylaxis. 1987 Prog. Clin. Biol. Res. pmid:3118384
Shalit M et al. Platelet-activating factor both stimulates and "primes" human polymorphonuclear leukocyte actin filament assembly. 1987 Blood pmid:3118991
Touqui L et al. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets. 1987 Biochem. J. pmid:3109377
Sheth KJ et al. Reversal of central nervous system involvement in hemolytic uremic syndrome by use of plasma exchanges. 1987 Clin Pediatr (Phila) pmid:3119270
Sage SO and Rink TJ The kinetics of changes in intracellular calcium concentration in fura-2-loaded human platelets. 1987 J. Biol. Chem. pmid:3119586
Moodley I and Stuttle A Evidence for a dual pathway in platelet activating factor-induced aggregation of rat polymorphonuclear leucocytes. 1987 Prostaglandins pmid:3035617
Camussi G et al. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. 1987 J. Exp. Med. pmid:3119758